Pregnancy: The safety of Meropenem Trihydrate (MEROP) Injection in human pregnancy has not been evaluated. Animal studies have not shown any adverse effect on the developing fetus. The only adverse effect observed in animal reproductive studies was an increased incidence of abortions in monkeys at 13 times the expected exposure in man. Meropenem Trihydrate (MEROP) Injection should not be used in pregnancy unless the potential benefit justifies the potential risk to the fetus. In every case, it should be used under the direct supervision of the physician.
Lactation: Meropenem Trihydrate (MEROP) Injection is detectable at very low concentrations in animal breast milk. Meropenem Trihydrate (MEROP) Injection should not be used in breast-feeding women unless the potential benefit justifies the potential risk to the baby.
Other Services
Country
Support
Account
Sign Out